iNCOVACC, a brand-new domestic drug, has been introduced by Bharat Biotech to aid in the fight against COVID 19. The nasal Covid vaccine ha...

According to the association, the hospitals may be allowed to charge ₹100 from those taking the shot towards logistics cost and honorarium....

Bharat Biotech has recently introduced its intranasal Covid vaccine, which will be given as a booster dose, as concerns about the Covid BF....

"We have written to Bharat Biotech, asking how we can procure the supply, about the pricing, etc," a senior executive at a private hospital...

The Union Health Ministry has approved Bharat Biotech's intranasal Covid vaccine, iNCOVACC, for use as a booster dose. The vaccine is avail...

The vaccine, iNCOVACC (BBV154), is available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and s...

The Central Drugs Standard Control Organisation (CDSCO) gave its nod to the vaccine for use as both primary series as well as a heterologou...

According to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...

On-going free vaccination programme through Govt Vaccination Centres for first and second dose as well as Precaution Dose to Healthcare Wor...

The announcement comes just hours after the Centre announced that the precaution dose (booster) of COVID-19 can now be administered to all ...

The trials of the Intranasal vaccine will take place at nine different sites of the country.

Several large companies including Tata Steel, Vedanta, Lupin, ITC, Panasonic and Mindtree are working on plans to organise vaccination driv...

The booster dose, or 'precautionary' dose as the government is calling it, is allowed from January 10 for people who are 60 and above with ...

The presence of at least two variants with different treatment requirements calls for stepped-up genome sequencing, enhanced testing option...

The variant's global spread suggests it could have a major impact on the COVID-19 pandemic, and the time to contain it is now before more O...

Adar Poonawalla, chief executive officer of Serum Institute of India, shares his journey and how his company overcame a plethora of challen...

The worst way to determine when boosters are needed would be to wait for infection rates to rise in vaccinated people. It would be the simp...